Your shopping cart is currently empty

YG1702, a potent inhibitor specific to ALDH18A1, suppresses the proliferation of MYCN-amplified neuroblastoma (NB) and reduces MYCN expression. This compound exhibits high-affinity physical interaction with ALDH18A1, which may influence its enzymatic activity [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks | 8-10 weeks |
| Description | YG1702, a potent inhibitor specific to ALDH18A1, suppresses the proliferation of MYCN-amplified neuroblastoma (NB) and reduces MYCN expression. This compound exhibits high-affinity physical interaction with ALDH18A1, which may influence its enzymatic activity [1]. |
| In vivo | YG1702, administered intraperitoneally at a dosage of 45 mg/kg every three days for a total of three administrations, inhibited the growth of xenografts in tumor-bearing mice [1]. |
| Molecular Weight | 478.56 |
| Formula | C23H30N2O7S |
| Cas No. | 724737-08-0 |
| Smiles | O=C(OCCOC)C1=C(NC(=C(C(=O)OCCSC(C)C)C1C=2C=CC=CC2N(=O)=O)C)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.